SANARA MEDTECH INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-4
Book Value Per Share
$1
Free Cash Flow Per Share
$0
Cash Per Share
$2
Revenue Per Share
$12
OCF Per Share
$1
Return on Equity
-165.7%
Return on Assets
-46.7%
Return on Invested Capital
9.5%
Debt to Equity
7.74
Current Ratio
1.80
Quick Ratio
1.59
Asset Turnover
1.28
Days Sales Outstanding
—
Days Payables Outstanding
—
Days Inventory On Hand
191.64
Cash Conversion Cycle
—
R&D / Revenue
4.9%
SBC / Revenue
5.0%
Capex / Revenue
4.5%
Working Capital
$15M
Net Current Asset Value
$-33M
Invested Capital
$52M
OCF / Net Income
-0.18
FCF / Net Income
-0.06
Accruals Ratio (Sloan)
-60.8%
Net Debt
$29M
Net Debt / EBITDA
2.61
Interest Coverage
1.08
Cash Coverage
1.00
Capex Coverage
1.47
Tangible Common Equity
$-16M
TCE / Total Assets
-22.4%
Goodwill / Total Assets
4.9%
NOPAT
$6M
Cash ROIC
3.5%
WC / Revenue
14.5%
Capex / D&A
1.17
Reinvestment Rate
9.3%
Total Payout Ratio
—
Asset Growth vs Revenue Growth
-36.2%
Revenue 5Y CAGR
45.9%
EBITDA 5Y CAGR
—
Book Value 5Y CAGR
0.3%
Stock Price (FY-end)
$23
Market Cap
$201M
P/E Ratio
—
P/S Ratio
1.95
P/B Ratio
33.91
P/TB Ratio
22.86
P/OCF Ratio
29.67
P/FCF Ratio
93.17
Enterprise Value
$231M
EV / EBITDA
20.51
EV / Sales
2.24
EV / FCF
106.78
FCF Yield
1.1%
Shareholder Yield
-2.6%
Buyback Yield
—
R&D Yield
2.5%
Capex Yield
2.3%
Operating Leverage
25.31
Graham Number
—
Shares Variation (YoY)
1.6%
Beta (5Y)
1.18
Cost of Equity
10.4%
Cost of Debt (after tax)
11.6%
WACC
10.6%
ROIC - WACC Spread
-1.2%
52W High
$38
52W Low
$19
Trailing Return 1Y
-30.3%
Trailing Return 5Y
-55.1%
F-Score (Piotroski)
4.00
Z-Score (Altman)
2.35
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.